Literature DB >> 2463824

Identification of lipid components of human serum lipoproteins involved in the inhibition of Sindbis virus infectivity, hemagglutination, and hemolysis.

P Mastromarino1, C Conti, S Rieti, N Orsi.   

Abstract

Human serum high density lipoproteins (HDL), low density lipoproteins (LDL) and very low density lipoproteins (VLDL) were isolated and tested for their ability to inhibit Sindbis virus infectivity, hemagglutination and hemolysis. VLDL and LDL produced a strong reduction on both viral infectivity on Vero cell monolayers and attachment and fusion with erythrocytes, whereas HDL appeared to be only a weak inhibitor. Lipid and protein components were extracted from each class of lipoproteins to identify the molecules responsible for the inhibiting activity. Only the lipid moiety was found to inhibit Sindbis virus biological activities. Among the individual lipid components of lipoproteins, neutral lipids (cholesterol, oleic acid and palmitic acid) and negatively charged phospholipids (phosphatidylserine and phosphatidylinositol) and glycolipids (GM 3 ganglioside and cerebroside sulphate) were able to neutralize the virus suggesting that either hydrophobic or electrostatic interactions are involved in the inhibition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463824     DOI: 10.1007/bf01311096

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

1.  Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins.

Authors:  J C Leong; J P Kane; O Oleszko; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

2.  Sera and cerebrospinal fluids from normal uninfected sheep contain a visna virus inhibiting factor.

Authors:  H Thormar; H M Wisniewski; F H Lin
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

3.  Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH.

Authors:  P Mastromarino; C Conti; P Goldoni; B Hauttecoeur; N Orsi
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

4.  Interaction of Sindbis virus with liposomal model membranes.

Authors:  J J Mooney; J M Dalrymple; C R Alving; P K Russell
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

5.  Inhibition of rabies virus infection by a soluble membrane fraction from the rat central nervous system.

Authors:  C Conti; B Hauttecoeur; M J Morelec; B Bizzini; N Orsi; H Tsiang
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Improved determination of total serum lipids by the sulfo-phospho-vanillin reaction.

Authors:  C S Frings; T W Fendley; R T Dunn; C A Queen
Journal:  Clin Chem       Date:  1972-07       Impact factor: 8.327

7.  Chicken fetal antigens: role as cell surface receptors for Sindbis virus hemagglutinin.

Authors:  B G Sanders; K M Wan; K Kline; R F Garry; H R Bose
Journal:  Virology       Date:  1980-10-15       Impact factor: 3.616

8.  Haemolysis by two alphaviruses: Semliki Forest and Sindbis virus.

Authors:  P Väänänen; L Kääriäinen
Journal:  J Gen Virol       Date:  1979-06       Impact factor: 3.891

9.  Sindbis virus receptor protein of BHK cells.

Authors:  E Duda; K Berencsi
Journal:  Acta Virol       Date:  1980-03       Impact factor: 1.162

10.  Use of Semliki forest virus to identify lipid-mediated antiviral activity and anti-alphavirus immunoglobulin A in human milk.

Authors:  J K Welsh; I J Skurrie; J T May
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  2 in total

1.  Involvement of gangliosides in the interaction between BK virus and Vero cells.

Authors:  L Sinibaldi; P Goldoni; V Pietropaolo; C Longhi; N Orsi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Effect of polyions on the early events of Sindbis virus infection of Vero cells.

Authors:  P Mastromarino; C Conti; R Petruzziello; R Lapadula; N Orsi
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.